English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Genentech Inc.
Press release submission
| Sep 16, 2018
GENENTECH INC: FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form of Juvenile Arthritis
Trending
+
Pharmaceuticals
Patient Daily
| Dec 17, 2024
Lung association warns against combined risks of smoking and radon
+
Pharmaceuticals
Patient Daily
| Dec 20, 2024
Discovery of replication hubs may lead to new antiviral therapies for norovirus
Patient Daily
| Dec 23, 2024
Patient Advocacy Group: ‘Policymakers must remove barriers to the development and delivery of innovative’ health care
+
Pharmaceuticals
Patient Daily
| Dec 20, 2024
California student returns home after receiving life-saving heart transplant
